Research on cranial osteopathic manipulation for TBI treatment has received $2.17 million from the NIH. This funding supports Virginia Tech’s Pamela VandeVord and Edward Via College of Osteopathic Medicine’s Gunnar Brolinson. Their collective efforts aim to explore innovative non-invasive
Pancreatic cancer, recognized for its aggressive nature and limited treatment options, remains one of the most challenging malignancies to manage. Researchers at the Perelman School of Medicine, University of Pennsylvania, and Penn Medicine's Abramson Cancer Center have recently unveiled promising
The single-use bioprocessing connectors market is witnessing an unprecedented surge, revolutionizing the realm of biopharmaceutical production across the globe. This article delves into the multifaceted dynamics driving this market growth, exploring its crucial segments, regional variations, and
The dawn of holography technology marks a revolutionary period in healthcare, enhancing diagnostic capabilities, surgical planning, and medical education. With predictions of the global medical holography market reaching $7.11 billion by 2029, the healthcare sector stands on the brink of profound
Ivan Kairatov is a Biopharma expert, with deep knowledge in tech and innovation in the industry and experience in research and development. Today, we will discuss the intricacies of protein kinase research, the role of AI in predicting interactions, and the development of KinasePred. Can you
Parkinson's disease, a devastating neurodegenerative disorder, is characterized by the relentless loss of dopaminergic neurons, which leads to significant motor dysfunction and a decline in overall quality of life. Central to the pathology of PD are aggregates of alpha-synuclein protein and
